NIH taps Nvidia to co-develop AI tools for brain, liver cancer clinical trials

Jessica Kim Cohen - Print  | 

The National Institutes of Health is partnering with technology company Nvidia to create artificial intelligence tools that support clinical trials.

Researchers and engineers from Nvidia will work alongside clinicians at the NIH Clinical Center, a Bethesda, Md.-based research hospital that conducts more than 1,600 clinical trials each year. Together, the team members will co-develop AI tools that combine imaging, genomic and clinical data to deliver precision medicine to patients with brain and liver cancers.

The partnership will focus on using deep learning — a type of AI that learns over time by extracting patterns from a data set — to characterize and measure tumors from radiological images. Along with taking these measurements, the AI tools will also incorporate additional data, such as biomarkers, to inform predictive and personalized medicine for patients.

Elizabeth Jones, MD, director of the department of radiology and imaging sciences at the NIH Clinical Center, said of the partnership: "Applying a powerful tool such as deep learning to medicine will require a truly multidisciplinary team of physicians, hospitals and computer scientists to work together to help realize the potential of computer models for medical imaging."

More articles on artificial intelligence:
Amazon adds 3 'HIPAA-eligible' AI tools to cloud service
CMS to launch AI challenge
Northwestern introduces AI tool to help medical assistants conduct sonograms

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

To receive the latest hospital and health system business and legal news and analysis from Becker's Hospital Review, sign-up for the free Becker's Hospital Review E-weekly by clicking here.